Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DYNEXANgival 1% versus placebo for acute oral mucosal pain in adults
2009-011901-18Phase 3Active
- Sponsor
- Kreussler Pharma
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in aphthosis (RAS) and Traumatic oral mucosal lesion comparing DYNEXANgival 1% (lidocaine buccal cream) with Placebo buccal cream (2 arms). Primary endpoint: Reduction in pain intensity on visual analogue scale (VAS). Started May 2009; status: active.
02
Drugs
lidocaine
03
Conditions
aphthosis (RAS)Traumatic oral mucosal lesion
Beyond the preview
Go deeper on 2009-011901-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011901-18.